Ongoing Research support |
||
|---|---|---|
| NIH/NCI 1SC1CA182844-02 | Contel (PI) | 07/01/13-06/30/2017 |
| Titanium-gold-based chemotherapeutics for prostate and kidney cancer | $1,413,000 | |
| Tow Foundation | Contel (PI) | 06/01/15-05/31/2017 |
| Tow Professor 2015-2016 | $25,000 (for research) | |
|
||
| CUNY-Advanced Science Research Center (SEED grants) | Contel (PI) | 06/01/15-05/31/2016 |
| Improving selectivity and delivery of potential organometallic-based cancer chemotherapeutics by using peptide- and carbohydrate- amphiphiles as mobile nanocarriers | $10,000 | |
| NIH/NCI 1R13CA200223-01A1 | Contel(PI) | 09/01/2015-05/31/2016 |
| Organization Conferences: 1st International Symposium on Clinical and Experimental Metallodrugs in Medicine: Cancer Chemotherapy (CEMM).Honolulu (UHCC) December 2015 |
$5000 | |
| NIH/NIGM SC2GM082307 | Contel (PI) | 02/01/10-06/30/2013 |
| Organogold phosphorus-containing compounds as anticancer agents | $471,000 | |
| PSC-CUNY Research Award 2009 | Contel (PI) | 07/01/09-06/30/2010 |
| Gold(III) compounds as anti-cancer agents | $3,300 | |
| PSC-CUNY Research Award 2008 | Contel (PI) | 07/01/08-06/30/2009 |
| Gold compounds as greener oxidation homogeneous catalysts | $3,500 | |
| PSC-CUNY New Faculty Research Award 2007 | Contel (PI) | 07/01/07-06/30/2009 |
| Gold compounds as environmentally benign catalysts for reactions with potential industrial applications | $3,900 | |